Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Peripheral Artery Disease Market Size Changed, over the years?

In recent times, the market size for peripheral artery disease has seen a robust expansion. A surge from $4.31 billion in 2024 to a projected $4.63 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.5%, is expected. The historic growth rate is attributed to factors such as increasing risk prevalence, the growing number of elderly individuals, clinical research & evidence-based healthcare, awareness & screening initiatives, and government healthcare policies.

How Much Will the Peripheral Artery Disease Market Be Worth in 2029?

The market size of peripheral artery disease is predicted to experience notable expansion in the upcoming years. It is projected to reach $6.23 billion by 2029, growing at a compounded annual growth rate (CAGR) of 7.7%. This growth during the forecast period is connected to efforts towards patient-centric care, advancements in minimally invasive techniques, developments in digital health and remote surveillance, the approach towards regenerative medicine, and targeted pharmaceutical treatments. Major anticipated trends during the forecast period encompass healthcare fairness initiatives, the incorporation of wearable technology, the growth of home-based rehabilitation, patient-reported outcomes (pros), and a transition to outpatient facilities.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Which is the Largest Company in the Peripheral Artery Disease Market?

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

What Are the Main Market Drivers in the Peripheral Artery Disease Industry?

The increased occurrence of peripheral artery disorders is projected to fuel the expansion of the peripheral artery disease market in the future. Peripheral artery disease entails the constriction or obstruction of arteries located outside the heart, often in the legs, causing decreased blood circulation and potential complications. Treatments for peripheral artery disease aim to alleviate the symptoms of the disease, improve mobility and minimize the risk of serious complications, thereby enhancing patient living conditions. For example, as per the American Heart Association in June 2023, a US-based non-profit organization, it is speculated that the disease affects between 7 to 12 million people in the United States and 200 million individuals worldwide. Thus, the growing prevalence of peripheral artery conditions is accelerating the expansion of the peripheral artery disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

How Is the Peripheral Artery Disease Market Segments Structured?

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

What Strategic Trends Are Transforming the Peripheral Artery Disease Market?

One key trend that is emerging in the peripheral artery disease market is the adoption of cutting-edge technology. Major businesses in the market are utilizing advanced surgical procedures to maintain their dominance. Notably, in November 2022, Genesis MedTech Group, a medical device company based in Singapore, launched a new product called Chocolate Touch paclitaxel DCB catheter. This Percutaneous Transluminal Angioplasty (PTA) catheter serves as a treatment option for individuals with superficial femoral artery and popliteal artery disease. The innovative feature of the Chocolate Touch drug-coated balloon is its combination of a next-generation angioplasty platform with the delivery of a therapeutic agent. This device employs pillow-like structures coated with a medicinal compound to selectively open targeted areas, providing an alternate treatment solution to standard drug-coated balloon angioplasty in peripheral artery disease patients. Consequently, the balloon’s surface area is increased, enhancing the drug delivery to the vessel wall and eliminating the need for permanent implants.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Global Regions Offer the Highest Growth in the Peripheral Artery Disease Market?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

This Report Delivers Insight On:

1. How big is the peripheral artery disease market, and how is it changing globally?

2. Who are the major companies in the peripheral artery disease market, and how are they performing?

3. What are the key opportunities and risks in the peripheral artery disease market right now?

4. Which products or customer segments are growing the most in the peripheral artery disease market?

5. What factors are helping or slowing down the growth of the peripheral artery disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model